Cyclooxygenase-1 (COX-1), but not COX-2, is expressed at high levels in the early stages of human epithelial ovarian cancer where it seems to play a key role in cancer onset and progression. As a consequence, COX-1 is an ideal biomarker for early ovarian cancer detection. A series of novel fluorinated COX-1-targeted imaging agents derived from P6 was developed by using a highly selective COX-1 inhibitor as a lead compound. Among these new compounds, designed by structural modification of P6, 3-(5-chlorofuran-2-yl)-5-(fluoromethyl)-4-phenylisoxazole ([(18/19)F]-P6) is the most promising derivative [IC50 = 2.0 μM (purified oCOX-1) and 1.37 μM (hOVCAR-3 cell COX-1)]. Its tosylate precursor was also prepared and, a method for radio[(18)F]chemistry was developed and optimized. The radiochemistry was carried out using a carrier-free K(18)F/Kryptofix 2.2.2 complex, that afforded [(18)F]-P6 in good radiochemical yield (18%) and high purity (>95%). In vivo PET/CT imaging data showed that the radiotracer [(18)F]-P6 was selectively taken up by COX-1-expressing ovarian carcinoma (OVCAR 3) tumor xenografts as compared with the normal leg muscle. Our results suggest that [(18)F]-P6 might be an useful radiotracer in preclinical and clinical settings for in vivo PET-CT imaging of tissues that express elevated levels of COX-1.
Cyclooxygenase-1 (n class="Gene">COX-1), but not COX-2, is expressed at high levels in the early stages of humanepithelial ovarian cancer where it seems to play a key role in cancer onset and progression. As a consequence, COX-1 is an ideal biomarker for early ovarian cancer detection. A series of novel fluorinated COX-1-targeted imaging agents derived from P6 was developed by using a highly selective COX-1 inhibitor as a lead compound. Among these new compounds, designed by structural modification of P6, 3-(5-chlorofuran-2-yl)-5-(fluoromethyl)-4-phenylisoxazole ([(18/19)F]-P6) is the most promising derivative [IC50 = 2.0 μM (purified oCOX-1) and 1.37 μM (hOVCAR-3 cell COX-1)]. Its tosylate precursor was also prepared and, a method for radio[(18)F]chemistry was developed and optimized. The radiochemistry was carried out using a carrier-free K(18)F/Kryptofix 2.2.2 complex, that afforded [(18)F]-P6 in good radiochemical yield (18%) and high purity (>95%). In vivo PET/CT imaging data showed that the radiotracer [(18)F]-P6 was selectively taken up by COX-1-expressing ovarian carcinoma (OVCAR 3) tumor xenografts as compared with the normal leg muscle. Our results suggest that [(18)F]-P6 might be an useful radiotracer in preclinical and clinical settings for in vivo PET-CT imaging of tissues that express elevated levels of COX-1.
Authors: Md Jashim Uddin; Brenda C Crews; Kebreab Ghebreselasie; Imran Huda; Philip J Kingsley; Mohammad Sib Ansari; Mohammed N Tantawy; Jeffery Reese; Lawrence J Marnett Journal: Cancer Prev Res (Phila) Date: 2011-09-07
Authors: Virgilio Evangelista; Stefano Manarini; Angelo Di Santo; Marta L Capone; Emanuela Ricciotti; Luigia Di Francesco; Stefania Tacconelli; Andrea Sacchetti; Sandra D'Angelo; Antonio Scilimati; Maria G Sciulli; Paola Patrignani Journal: Circ Res Date: 2006-02-16 Impact factor: 17.367
Authors: Md Jashim Uddin; Anna V Elleman; Kebreab Ghebreselasie; Cristina K Daniel; Brenda C Crews; Kellie D Nance; Tamanna Huda; Lawrence J Marnett Journal: ACS Med Chem Lett Date: 2014-10-12 Impact factor: 4.345
Authors: Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin Journal: Adv Funct Mater Date: 2020-03-03 Impact factor: 18.808
Authors: Andrew J Wilson; Oluwole Fadare; Alicia Beeghly-Fadiel; Deok-Soo Son; Qi Liu; Shilin Zhao; Jeanette Saskowski; Md Jashim Uddin; Cristina Daniel; Brenda Crews; Brian D Lehmann; Jennifer A Pietenpol; Marta A Crispens; Lawrence J Marnett; Dineo Khabele Journal: Oncotarget Date: 2015-08-28
Authors: Md Jashim Uddin; Andrew J Wilson; Brenda C Crews; Paola Malerba; Md Imam Uddin; Philip J Kingsley; Kebreab Ghebreselasie; Cristina K Daniel; Michael L Nickels; Mohammed N Tantawy; Elma Jashim; H Charles Manning; Dineo Khabele; Lawrence J Marnett Journal: ACS Omega Date: 2019-05-24
Authors: Francesca Zalfa; Maria Grazia Perrone; Savina Ferorelli; Luna Laera; Ciro Leonardo Pierri; Anna Tolomeo; Vincenzo Dimiccoli; Giuseppe Perrone; Anna De Grassi; Antonio Scilimati Journal: Cancers (Basel) Date: 2022-08-02 Impact factor: 6.575